Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools
In the past decade, significant progresses have taken place in the field of cancer immunotherapy. Tumor-targeting immunotherapies are being developed for most human cancers, including melanoma, prostate cancer, glioblastoma, sarcoma, lung carcinoma and hepatocellular carcinoma. The FDA has approved...
I tiakina i:
Kaituhi matua: | Chao Ma (auth) |
---|---|
Ētahi atu kaituhi: | Antoni Ribas (auth), Rong Fan (auth) |
Hōputu: | Tāhiko Wāhanga pukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Frontiers Media SA
2014
|
Rangatū: | Frontiers Research Topics
|
Ngā marau: | |
Urunga tuihono: | DOAB: download the publication DOAB: description of the publication |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
Tumor Cell/Dendritic Cell Interactions and the Influence of Tumors on Dendritic Cell-mediated Anti-Tumor Immune Responses and Dendritic Cell-Based Tumor Immunotherapies
mā: Timothy Bullock
I whakaputaina: (2014) -
HIV and Cancer Immunotherapy: Similar Challenges and Converging Approaches
I whakaputaina: (2020) -
The Role of Chemoattractants in the Tumor Microenvironment
I whakaputaina: (2020) -
Good News - Bad News: The Two Faces of Immune Privilege
mā: Joan Stein-Streilein
I whakaputaina: (2014) -
Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
I whakaputaina: (2020)